Peter Cabot

Professor Peter Cabot is the Professor and Head of School in the School of Pharmacy at the University of Queensland. He holds expertise in pain mechanisms, opioid research, and drug delivery systems. His academic journey includes a Bachelor of Applied Science from Charles Sturt University and a PhD from the University of Queensland.

Research interests focus on peripheral mechanisms of pain, biotransformation of opioids, and natural products for drug discovery. Cabot’s work bridges translational science, exploring novel opioid ligands and inflammatory pathways, with applications in clinical pain management and personalized therapies.

His recent studies highlight advancements in CRP’s role in chronic pain, opioid-based analgesics, and nanoparticle drug delivery. Notable contributions include investigations into wasp venom-derived peptides and mesoporous silica nanoparticles for targeted cancer therapy.

Cabot has authored over 100 peer-reviewed articles and holds patents for peptide-based therapies. His leadership in the School of Pharmacy emphasizes fostering innovation in pharmaceutical sciences and translational health research.